Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-19

Clinical Trial Update: Riluzole in Spinal Cord Injury Study [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for riluzole in spinal cord injury shows Phase 2 and Phase 3 studies terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riluzole (riluzole)

Snippet

Sponsor: AOSpine North America Research Network | Conditions: Spinal Cord Injury | Phase 2, Phase 3 | Status: TERMINATED